Same-day Dilapan insertion before second-trimester dilatation and evacuation for a fetal anomaly or death.
OBJECTIVE
To evaluate the efficacy of same-day Dilapan insertion prior to nonelective second-trimester dilatation and evacuation.


METHODS
Eighty women had Dilapan inserted six to eight hours prior to surgery. Degree of cervical dilatation was assessed after Dilapan was removed.


RESULTS
Seventy-eight of 80 women had adequate cervical dilatation from a single, same-day Dilapan insertion. There were no major complications.


CONCLUSIONS
Same-day Dilapan insertion prior to planned second-trimester dilatation and evacuation is safe and effective.
Patsner
B
B
New Jersey Gynecologic Oncology, Little Silver 07739, USA.
D000019:Abortifacient Agents / Q000627:therapeutic use*; D000032:Abortion, Therapeutic / Q000379:methods*; D000282:Administration, Intravaginal; D003131:Combined Modality Therapy; D000013:Congenital Abnormalities; D005260:Female; D005313:Fetal Death; D006801:Humans; D010865:Pilot Projects; D011108:Polymers / Q000627:therapeutic use*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011292:Premedication; D014619:Vacuum Curettage / Q000379:methods*
D000019:Abortifacient Agents; D011108:Polymers; C077755:dilapan